PP
CLBT icon

PDT Partners’s Cellebrite CLBT Stock Holding History

PDT Partners’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,400
Closed -$143K – 522
2026
Q1 		$143K Buy
+10,400
New +$157K 0.01% 513
2025
Q3 		– Sell
-113,527
Closed -$1.82M – 603
2025
Q2 		$1.82M Sell
113,527
-92,205
-45% -$1.64M 0.1% 322
2025
Q1 		$4M Buy
205,732
+82,890
+67% +$1.74M 0.28% 104
2024
Q4 		$2.71M Buy
122,842
+97,539
+385% +$1.88M 0.24% 143
2024
Q3 		$426K Buy
+25,303
New +$375K 0.04% 536

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

PDT Partners's CLBT Position: Q2 2026 in Review

PDT Partners sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 10,400 shares — an estimated $143K sold.

PDT Partners first reported a position in CLBT in Q3 2024 and held it in 5 quarters. The position peaked at $4M in Q1 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • PDT Partners reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • PDT Partners sold 10,400 Cellebrite shares in Q2 2026, an estimated $143K.
  • PDT Partners first reported a position in Cellebrite in Q3 2024 and held it in 5 quarters.
  • PDT Partners's Cellebrite position peaked at $4M in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.